Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000820289 | SCV000960996 | benign | Wilms tumor 1 | 2024-04-10 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV001816904 | SCV002065347 | likely benign | not specified | 2021-06-01 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV005049708 | SCV005683299 | uncertain significance | Wilms tumor 1; Simpson-Golabi-Behmel syndrome type 1 | 2024-03-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004754575 | SCV005347862 | likely benign | GPC3-related disorder | 2024-06-03 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |